Vecuronium Bromide: Uses, Dosage, Side Effects & Brands | MedexInfo

Vecuronium Bromide

Rx

Generic NameVecuronium Bromide

Therapeutic ClassNeuromuscular Blocking Agent

Max / 24h0.1 mg/kg IV

Common Dose0.08–0.1 mg/kg IV for intubation; 0.01–0.015 mg/kg IV for maintenance

PregnancyUse only if benefit outweighs risk (Category C)

Indications ▼

Facilitation of endotracheal intubation

Muscle relaxation during surgery

Adjunct to general anesthesia for mechanical ventilation

Mechanism & Pharmacokinetics ▼

Mechanism: Non-depolarizing neuromuscular blocker that competitively inhibits acetylcholine at nicotinic receptors at the neuromuscular junction, preventing muscle contraction.

Pharmacokinetics: Rapid onset after IV injection; duration 25–40 minutes (intubation dose). Metabolized hepatically, excreted in bile and urine. Minimal accumulation with single doses.

Dosage & Administration ▼

Condition	Recommended Dose	Frequency
Intubation	0.08–0.1 mg/kg	IV, single dose
Maintenance of muscle relaxation	0.01–0.015 mg/kg	IV as needed every 20–40 min
Continuous infusion (ICU / ventilation)	0.8–1.5 µg/kg/min	IV infusion, titrate per response

Note: Administer only under monitoring; ensure availability of resuscitation equipment and reversal agents (e.g., neostigmine).

Side Effects ▼

Transient hypotension or bradycardia

Flushing

Muscle weakness or prolonged paralysis

Rare: Anaphylaxis, respiratory depression

Contraindications ▼

Hypersensitivity to vecuronium or other aminosteroid neuromuscular blockers

Known or suspected neuromuscular disorders (e.g., myasthenia gravis) without caution

Patients with uncontrolled hypotension or shock without monitoring

Drug Interaction ▼

Aminoglycosides or tetracyclines: enhanced neuromuscular blockade

Magnesium sulfate: potentiates effect

Cholinesterase inhibitors: may reverse blockade

Other anesthetics: additive muscle relaxation

Pregnancy & Lactation ▼

Use only if clearly needed; category C

Safety in breastfeeding unknown; caution advised

Clinical / Research Summary ▼

Therapeutic Role: Essential non-depolarizing neuromuscular blocker for surgical muscle relaxation and mechanical ventilation.

Clinical Effectiveness: Provides predictable onset and duration of paralysis; commonly used for intubation and surgery.

Safety Profile: Generally safe under monitoring; requires resuscitation readiness. Monitor neuromuscular function, heart rate, and blood pressure.

Current Research: Focus on optimized dosing, reversal strategies, and interactions with other anesthetic agents.

Patient Counseling Points ▼

Administer only in hospital settings under anesthesia monitoring

Do not self-administer

Ensure resuscitation equipment is ready

Inform anesthesia team of all medications and neuromuscular disorders

Storage & Handling ▼

Store at 2–8°C, protect from light

Do not freeze; keep out of reach of children

Brand Names (Bangladesh & Global) ▼

Bangladesh (Local Brands):

Nor Q Vecuron Norcuron

Global / International Brands:

Norcuron Vecuron

Medical Disclaimer: This information is intended for educational purposes only and must not replace professional medical advice.

Reference Hubs:

• Drug Class: Neuromuscular Blockers • Conditions: Surgery • Conditions: Mechanical Ventilation